Stroke in COVID-19: a systematic review and meta-analysis

S Nannoni, R de Groot, S Bell… - International journal of …, 2021 - journals.sagepub.com
Background Coronavirus disease 2019 (COVID-19) has become a global pandemic,
affecting millions of people. However, the relationship between COVID-19 and acute …

Neurological involvement in COVID-19 and potential mechanisms: a review

G Aghagoli, B Gallo Marin, NJ Katchur, F Chaves-Sell… - Neurocritical care, 2021 - Springer
As the current understanding of COVID-19 continues to evolve, a synthesis of the literature
on the neurological impact of this novel virus may help inform clinical management and …

COVID-19 and obesity in childhood and adolescence: a clinical review

CA Nogueira-de-Almeida, LA Del Ciampo… - Jornal de …, 2020 - SciELO Brasil
Objective: To identify factors that contribute to the increased susceptibility and severity of
COVID-19 in obese children and adolescents, and its health consequences. Sources …

D-dimer, fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: a narrative review

I Eljilany, AN Elzouki - Vascular health and risk management, 2020 - Taylor & Francis
Abstract Coronavirus disease 2019 (COVID-19) emerged from the West District of Southern
China Seafood Wholesale Market in late December 2019 and has been declared a global …

Thrombotic complications in patients with COVID-19: pathophysiological mechanisms, diagnosis, and treatment

A Gąsecka, JA Borovac, RA Guerreiro… - … drugs and therapy, 2021 - Springer
Introduction Emerging evidence points to an association between severe clinical
presentation of COVID-19 and increased risk of thromboembolism. One-third of patients …

SARS-CoV-2 and coagulation disorders in different organs

S Vinayagam, K Sattu - Life sciences, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is a prominent pandemic disease that
emerged in China and hurriedly stretched worldwide. There are many reports on COVID-19 …

Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19

C Guervilly, A Bonifay, S Burtey, F Sabatier… - Blood …, 2021 - ashpublications.org
Abstract Coronavirus disease 2019 (COVID-19) has become one of the biggest public
health challenges of this century. Severe forms of the disease are associated with a thrombo …

SARS-CoV-2 leads to a small vessel endotheliitis in the heart

U Maccio, AS Zinkernagel, SM Shambat, X Zeng… - …, 2021 - thelancet.com
Abstract Background SARS-CoV-2 infection (COVID-19 disease) can induce systemic
vascular involvement contributing to morbidity and mortality. SARS-CoV-2 targets epithelial …

Anticoagulation in COVID-19: current concepts and controversies

A Chandra, U Chakraborty, S Ghosh… - Postgraduate Medical …, 2022 - academic.oup.com
Rising incidence of thromboembolism secondary to COVID-19 has become a global
concern, with several surveys reporting increased mortality rates. Thrombogenic potential of …

Marked factor V activity elevation in severe COVID‐19 is associated with venous thromboembolism

JA Stefely, BB Christensen, T Gogakos… - American journal of …, 2020 - Wiley Online Library
Coagulopathy causes morbidity and mortality in patients with coronavirus disease 2019
(COVID‐19) due to severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) …